CNTX

Context Therapeutics Inc.

Healthcare · Biotechnology

$106.27 sample

+1.84 (+1.76%) 1D

Market cap

$148.2B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-17

Alerts

8

Price$106.27 +4.55% 3M daily closessample

106.2792.84

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider sell: 10% owner
Sep 22INSInsider buy: General Counsel
Sep 17SEC8-K filed: material event
Sep 14INSInsider sell: EVP, Operations
Sep 04INSInsider sell: Director
Aug 27SECForm 144 filed
Aug 20INSInsider buy: General Counsel
Aug 12INSInsider buy: 10% owner

Sign up to see the real CNTX record →

Company facts

SEC EDGAR registration

Name: Context Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -27sample, -100 to +100
Reporting currency: USD

Who is positioning in CNTX

sample

Insiders: 32 insider transactions over 90 days, net selling, $579.2M
Congress: 1 members traded over 90 days
Institutions · 13F: 18 funds hold $2.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.0B +15.0% y/y

Q4 2024Q3 2026

Inventory$5.2B +11.8% y/y

Q4 2024Q3 2026

Accounts receivable$4.0B +7.1% y/y

Q4 2024Q3 2026

Total debt$11.0B +10.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $122.2B +7.9% 3M
Sample peer B: $58.9B +13.4% 3M
Sample peer C: $61.4B +14.9% 3M
Sample peer D: $67.0B +6.4% 3M
Sample peer E: $74.0B +6.9% 3M